Sun Pharmaceutical Industries Ltd. closed 10.99% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Sun Pharmaceutical Industries Ltd. closed 9.90% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

The global active pharmaceutical ingredients market size is projected to reach USD 359.45 billion by 2030, and it is expected to exhibit a CAGR of 5.85% from 2025 to 2030, according to a new report by ...

(Picture: Andrew McCaren/LNP) Scientists trialling experimental methods to try and fight global warming could be given the green light to start ‘dimming the sun’ within weeks. The Advanced ...

MUMBAI, India and TEL AVIV, Israel, April 24, 2025 /PRNewswire/ -- Sun Pharma (Reuters: SUN.BO) (Bloomberg: SUNP IN) (NSE: SUNPHARMA) (BSE: 524715) (Sun Pharmaceutical Industries Limited, and includes ...

H.C. Wainwright lowered the firm’s price target on Innate Pharma (IPHA) to $11 from $11.50 and keeps a Buy rating on the shares. The firm postponed the U.S. launch of IPH6101 to 2029 from ...

Systematix Group's Vishal Manchanda anticipates Q4 results for pharma companies to align with previous quarters, with high single-digit domestic growth. US growth, driven by high-value launches for ...

Perform material- and labor-effective extrusion with Thermo Scientific™ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...

Pharmaceutical companies are expected to post a strong performance for the January-March quarter of 2025 (Q4FY25), led by improved operational efficiency, a weaker rupee, and lower freight costs.

Most notable is the change from flat animations to add more 3D and interactive elements, including the addition of scenes to represent specific weather conditions. Samsung is going to add more ...

Buy SBI May Futures in the range of Rs 820–800. Sun Pharmaceutical has seen long liquidation throughout its uptrend, and the cumulative open interest has now dropped to its lowest level in six ...